BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210407T120000
DTEND;TZID=America/New_York:20210407T130000
DTSTAMP:20260404T150327
CREATED:20210412T213508Z
LAST-MODIFIED:20210412T213508Z
UID:10000231-1617796800-1617800400@ctl.cornell.edu
SUMMARY:Weill Digital Health Series 2: Regulatory Landscapes and Reimbursement Strategies and Why It Matters
DESCRIPTION:In 2017\, the FDA launched its Digital Health Action Plan with legislation specifically targeting digital health\, in which it intends to harness the potential of digital health in a conscientious manner. In this second session\, our guest experts will present an overview of the regulatory landscape and the challenges related to privacy and data protection. They will also address the future of reimbursement for digital health products. \n  \nPanelists: \n\nSally Bowden\, COO\, Renalytix AI\nMelissa Hudzik\, Senior Counsel\, Regulatory\nVernessa Pollard\, Partner\, McDermott Will & Emery\n\n  \nModerator: Lisa Placanica\, Senior Managing Director\, Center for Technology Licensing at Weill Cornell Medicine (WCM)
URL:https://ctl.cornell.edu/event/weill-digital-health-series-2-regulatory-landscapes-and-reimbursement-strategies-and-why-it-matters
CATEGORIES:CTL Events
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR